Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Prevalence and Causative Factors of Extrahepatic Collateral Arteries in 479 Patients

  • Chung, Jin-Wook (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, and Clinical Research Institute, Seoul National University Hospital) ;
  • Kim, Hyo-Cheol (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, and Clinical Research Institute, Seoul National University Hospital) ;
  • Yoon, Jung-Hwan (Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine) ;
  • Lee, Hyo-Suk (Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine) ;
  • Jae, Hwan-Jun (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, and Clinical Research Institute, Seoul National University Hospital) ;
  • Lee, Whal (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, and Clinical Research Institute, Seoul National University Hospital) ;
  • Park, Jae-Hyung (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, and Clinical Research Institute, Seoul National University Hospital)
  • 발행 : 2006.12.31

초록

Objective: We wanted to investigate the prevalence and causative factors of extrahepatic arterial blood supply to hepatocellular carcinoma (HCC) at its initial presentation and during chemoembolization. Materials and Methods: Between February 1998 and April 2000, consecutive 479 patients with newly diagnosed HCC were prospectively enrolled into this study. A total of 1629 sessions of transcatheter arterial chemoembolization (TACE) were performed in these patients (range: 1-15 sessions; mean: 3.4 sessions) until April 2004. For each TACE procedure, we determined the potential extrahepatic collateral arteries (ExCAs) depending on the location of the tumor, and we performed selective angiography of all suspected collaterals that could supply the tumor. The prevalence of ExCAs and the causative factors were analyzed. Results: At initial presentation, 82(17%) of these 479 patients showed 108 ExCAs supplying tumors. Univariate analysis showed that tumor size (p<0.01), patient age (p=0.02), a surface location (p<0.01), and a bare area location (p<0.01) were significantly associated with the presence of ExCAs. Multiple logistic regression analysis showed that only tumor size was predictive of ExCAs formation (p<0.01, odds ratio=1.737, confidence interval: 1.533 to 1.969). During repeated TACE sessions, 97 additional ExCAs were detected in 70 (14%) patients. The cumulative probability of ExCAs in patients with a large tumor $({\geq}5cm)$ was significantly higher than that for those patients with a small tumor (<5cm) (p<0.01). Conclusion: The presence of ExCAs supplying HCC is rather common, and the tumor size is a significant causative factor for the development of these collateral arteries.

키워드

참고문헌

  1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745- 750 https://doi.org/10.1056/NEJM199903113401001
  2. Carr BI. Hepatocellular carcinoma: current management and future trends. Gastroenterology 2004;127:S218-224 https://doi.org/10.1053/j.gastro.2004.09.036
  3. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171 https://doi.org/10.1053/jhep.2002.33156
  4. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442 https://doi.org/10.1053/jhep.2003.50047
  5. Nakakuma K, Tashiro S, Hiraoka T, Uemura K, Konno T, Miyauchi Y, et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983;52:2193-2200 https://doi.org/10.1002/1097-0142(19831215)52:12<2193::AID-CNCR2820521203>3.0.CO;2-R
  6. Kim JH, Chung JW, Han JK, Park JH, Choi BI, Han MC. Transcatheter arterial embolization of the internal mammary artery in hepatocellular carcinoma. J Vasc Interv Radiol 1995;6:71-74 https://doi.org/10.1016/S1051-0443(95)71059-4
  7. Chung JW, Park JH, Han JK, Choi BI, Kim TK, Han MC. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role. J Vasc Interv Radiol 1998;9:495-500 https://doi.org/10.1016/S1051-0443(98)70306-9
  8. Kim HC, Chung JW, Lee W, Jae HJ, Park JH. Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 2005;25:S25-S39 https://doi.org/10.1148/rg.25si055508
  9. Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996;198:33- 40 https://doi.org/10.1148/radiology.198.1.8539401
  10. Kwon JW, Chung JW, Song SY, Lim HG, Myung JS, Choi YH, et al. Transcatheter arterial chemoembolization for hepatocellular carcinomas in patients with celiac axis occlusion. J Vasc Interv Radiol 2002;13:689-694 https://doi.org/10.1016/S1051-0443(07)61845-4
  11. Song SY, Chung JW, Kwon JW, Joh JH, Shin SJ, Kim HB, et al. Collateral pathways in patients with celiac axis stenosis: angiographic-spiral CT correlation. Radiographics 2002;22:881- 893 https://doi.org/10.1148/radiographics.22.4.g02jl13881
  12. Nakai M, Sato M, Kawai N, Minamiguchi H, Masuda M, Tanihata H, et al. Hepatocellular carcinoma: involvement of the internal mammary artery. Radiology 2001;219:147-152 https://doi.org/10.1148/radiology.219.1.r01mr28147
  13. Miyayama S, Matsui O, Akakura Y, Yamamoto T, Nishida H, Yoneda K, et al. Hepatocellular carcinoma with blood supply from omental branches: treatment with transcatheter arterial embolization. J Vasc Interv Radiol 2001;12:1285-1290 https://doi.org/10.1016/S1051-0443(07)61553-X
  14. Won JY, Lee DY, Lee JT, Park SI, Kim MJ, Yoo HS, et al. Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2003;26:136-140 https://doi.org/10.1007/s00270-002-2629-y
  15. Park SI, Lee DY, Won JY, Lee JT. Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries. J Vasc Interv Radiol 2003;14:461-468 https://doi.org/10.1097/01.RVI.0000064856.87207.1E
  16. Miyayama S, Matsui O, Nishida H, Yamamori S, Minami T, Shinmura R, et al. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol 2003;14:1155-1161 https://doi.org/10.1097/01.RVI.0000086534.86489.10
  17. Couinaud C. Le foie: etudes anatomiques et chirurgicales. Paris, France: Masson, 1957;9-12
  18. Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology 1982;144:485-494 https://doi.org/10.1148/radiology.144.3.6285413
  19. Michels NA. Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the celiac axis. Cancer 1953;6:708-724 https://doi.org/10.1002/1097-0142(195307)6:4<708::AID-CNCR2820060411>3.0.CO;2-A
  20. Doppman JL, Girton M, Kahn R. Proximal versus peripheral hepatic artery embolization experimental study in monkeys. Radiology 1978;128:577-588 https://doi.org/10.1148/128.3.577
  21. Hirakawa M, Iida M, Aoyagi K, Matsui T, Akagi K, Fujishima M. Gastroduodenal lesions after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am J Gastroenterol 1988;83:837-840
  22. Arora R, Soulen MC, Haskal ZJ. Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals. J Vasc Interv Radiol 1999;10:1351-1356 https://doi.org/10.1016/S1051-0443(99)70242-3